The 5-HT1A receptor is a pharmacologically well characterized serotonin receptor subtype and it has long been investigated because of its involvement in several physio-pathological mechanisms and treatment of neurological diseases like ansia and depression. Serotonin (5-HT) also shows many non-neural functions such as essential hypertension, embryogenesis, follicle maturation and behavior. Moreover it exerts a growth factor function on different types of non-tumoral cells, and it was also found to be related to oncogenes. In fact, growth-stimulatory activity of serotonin in different human tumor cells has been reported. Recently, new chemical molecules binding the 5-HT1A receptor have been described as novel therapeutic entities useful in neuroprotection, cognitive impairment, Parkinson's Disease, pain treatment, malignant carcinoid syndrome and cancer. It was widely demonstrated that 5-HT1A receptor is involved in the carcinogenesis and consequently in many human tumor types, such as prostate, bladder, small cell lung, colonrectal and cholangiocarcinoma. Furthermore depending on the tumor type, 5-HT1A receptor antagonists were shown to be able to block the 5HT-induced increase in tumor growth. In this review we have focused our attention on each tumor type where the 5-HT1A receptor is involved, investigating the role of this molecular target and the different classes of compounds that have shown the capability to modulate it. The analyzed aspects could represent the hint for the medical chemists to develop novel molecules as selective 5-HT1A agents useful to further elucidate the role this therapeutic target.

The Role of 5-HT1A Receptor in the Cancer as a New Opportunity in Medicinal Chemistry / Corvino, Angela; Fiorino, Ferdinando; Severino, Beatrice; Saccone, Irene; Frecentese, Francesco; Perissutti, Elisa; Di Vaio, Paola; Santagada, Vincenzo; Caliendo, Giuseppe; Magli, Elisa. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - 25:(2018). [10.2174/0929867325666180209141650]

The Role of 5-HT1A Receptor in the Cancer as a New Opportunity in Medicinal Chemistry

Corvino, Angela;Fiorino, Ferdinando
;
Severino, Beatrice;Saccone, Irene;Frecentese, Francesco;Perissutti, Elisa;Di Vaio, Paola;Santagada, Vincenzo;Caliendo, Giuseppe;Magli, Elisa
2018

Abstract

The 5-HT1A receptor is a pharmacologically well characterized serotonin receptor subtype and it has long been investigated because of its involvement in several physio-pathological mechanisms and treatment of neurological diseases like ansia and depression. Serotonin (5-HT) also shows many non-neural functions such as essential hypertension, embryogenesis, follicle maturation and behavior. Moreover it exerts a growth factor function on different types of non-tumoral cells, and it was also found to be related to oncogenes. In fact, growth-stimulatory activity of serotonin in different human tumor cells has been reported. Recently, new chemical molecules binding the 5-HT1A receptor have been described as novel therapeutic entities useful in neuroprotection, cognitive impairment, Parkinson's Disease, pain treatment, malignant carcinoid syndrome and cancer. It was widely demonstrated that 5-HT1A receptor is involved in the carcinogenesis and consequently in many human tumor types, such as prostate, bladder, small cell lung, colonrectal and cholangiocarcinoma. Furthermore depending on the tumor type, 5-HT1A receptor antagonists were shown to be able to block the 5HT-induced increase in tumor growth. In this review we have focused our attention on each tumor type where the 5-HT1A receptor is involved, investigating the role of this molecular target and the different classes of compounds that have shown the capability to modulate it. The analyzed aspects could represent the hint for the medical chemists to develop novel molecules as selective 5-HT1A agents useful to further elucidate the role this therapeutic target.
2018
The Role of 5-HT1A Receptor in the Cancer as a New Opportunity in Medicinal Chemistry / Corvino, Angela; Fiorino, Ferdinando; Severino, Beatrice; Saccone, Irene; Frecentese, Francesco; Perissutti, Elisa; Di Vaio, Paola; Santagada, Vincenzo; Caliendo, Giuseppe; Magli, Elisa. - In: CURRENT MEDICINAL CHEMISTRY. - ISSN 0929-8673. - 25:(2018). [10.2174/0929867325666180209141650]
File in questo prodotto:
File Dimensione Formato  
CMC-2018.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 706.17 kB
Formato Adobe PDF
706.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/709879
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 19
social impact